A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data
2018
Journal of Cardiovascular Translational Research
Study Change in LVEF (%) myocardial perfusion or CCS Follow up timepoint Versus P-value Small animals Di Lascio[1] LVEF: Echocardiopgraphy 12 ± 11.2 % (cells) 16 ± 8.9 % (cells + RLX)
doi:10.1007/s12265-018-9785-1
pmid:29392536
pmcid:PMC5973989
fatcat:denwjdwtgffg3aybuvd56vybuu